During the past decade, BRCR Medical Center Inc. conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 13 clinical trials were completed, i.e. on average, 28.3% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 10 clinical trials were completed. i.e. 37% of trials that started reached the finish line.

Out of the total clinical trials conducted in "BRCR Medical Center Inc." #1 sponsor was "Astex Pharmaceuticals, Inc." with 3 trials, followed by "Karyopharm Therapeutics Inc" with 3 trials sponsored, "Molecular Templates, Inc." with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Shire" with 3 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "BRCR Medical Center Inc." #1 collaborator was "Akesobio Australia Pty Ltd" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Belgium and Luxembourg Gynaecological Oncology Group" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "BRCR Medical Center Inc." are "Myelodysplastic Syndromes" (5 trials), "Non Small Cell Lung Cancer" (4 trials), "Ulcerative Colitis" (4 trials), "Acute Myeloid Leukemia" (2 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "BRCR Medical Center Inc." in a lesser frequency.

Most popular intervention types in "BRCR Medical Center Inc." are "Drug" (45 trials), "Biological" (3 trials), "Device" (3 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Docetaxel" (4 trials), "Pembrolizumab" (4 trials), "Selinexor" (3 trials) and "ASTX727" (2 trials). Other intervention names were less common.

The vast majority of trials in "BRCR Medical Center Inc." are 45 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "BRCR Medical Center Inc.". undefined are not yet recruiting, 17 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in BRCR Medical Center Inc., undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in BRCR Medical Center Inc., 11 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".